Menlo Park, CA
Harnessing deep learning and lab automation to accelerate drug discovery in targeted protein degradation.
celeristx.comThese are collections Celeris Therapeutics is a part of. Click on the collection name to view similar companies.
Series Unknown
10,000,000 EUR
Grant
2,500,000 EUR
Seed
3,000,000 EUR
Pre Seed
600,000 EUR
Pre Seed
400,000 EUR
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Celeris Therapeutics.